Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT

Brochures and specifications

| 2014 | Agilent Technologies

HPLC, ICP/MS

Instrumentation

HPLC, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

Technical notes

| 2021 | Agilent Technologies

Software, ICP/MS

Instrumentation

Software, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

SPECTROSCOPY SOLUTIONS FOR PHARMACEUTICALS

Others

| 2016 | Agilent Technologies

UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, FTIR Spectroscopy

Instrumentation

UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, FTIR Spectroscopy

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

E&L: Streamlining LC/MS and GC/MS Workflows

Presentations

| 2018 | Agilent Technologies (ASMS)

GC/MSD, GC/MS/MS, GC/HRMS, GC/Q-TOF, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, ICP/MS

Instrumentation

GC/MSD, GC/MS/MS, GC/HRMS, GC/Q-TOF, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products

Posters

| 2012 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Agilent ICP-MS Journal (July 2017 – Issue 69)

Others

| 2017 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Environmental, Pharma & Biopharma, Semiconductor Analysis

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Technical notes

| 2014 | Agilent Technologies

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS

Others

| 2017 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

WCPS: Analytical Workflow for Elemental Extractables and Leachables in reference to USP and ICH Guidelines: Intravenous Bag Case Study

Posters

| 2017 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

ELIMINATE VARIABILITY WITH QUALITY BY DESIGN FOR PHARMACEUTICAL DEVELOPMENT

Meeting Regulatory Compliance Guidelines with Agilent ICP-MS MassHunter and OpenLab Server or ECM XT

SPECTROSCOPY SOLUTIONS FOR PHARMACEUTICALS

E&L: Streamlining LC/MS and GC/MS Workflows

WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products

Agilent ICP-MS Journal (July 2017 – Issue 69)

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS

WCPS: Analytical Workflow for Elemental Extractables and Leachables in reference to USP and ICH Guidelines: Intravenous Bag Case Study

Related content

New approach enhances muscle recovery in aged mice

Scientists from IOCB Prague are expanding the possibilities of using RNA in gene medicine

Virus attacking coccolithophore – marine alga that affects the Earth’s climate